Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.
暂无分享,去创建一个
A. Rapoport | G. Akpek | B. Meisenberg | A. Badros | O. Goloubeva | Robert A. Fenton | K. Ruehle | S. Westphal | C. Harris | Robert G. Fenton